Apoptosis is an innate immune response to viral infection that limits viral replication. However, the mechanisms by which cells detect viral infection and activate apoptosis are not completely understood. We now show that during Coxsackievirus infection, the viral protease 3C pro cleaves inhibitor of B␣ (IB␣). A proteolytic fragment of IB␣ then forms a stable complex with NF-B, translocates to the nucleus, and inhibits NF-B transactivation, increasing apoptosis and decreasing viral replication. In contrast, cells with reduced IB␣ expression are more susceptible to viral infection, with less apoptosis and more viral replication. IB␣ thus acts as a sensor of viral infection. Cleavage of host proteins by pathogen proteases is a novel mechanism by which the host recognizes and responds to viral infection.
A
poptosis is an innate immune response to viral infection (1, 2) . Virus infection can indirectly induce apoptosis of the host cell by stimulating immune effector cells, which in turn activate apoptosis of infected cells. Virus infection can also directly trigger apoptosis of host cells, but the mechanisms by which infected cells sense viral infection and activate programmed cell death are less well understood.
The family of NF-B transcription factors not only activates proinflammatory pathways in innate and adaptive immunity, but also plays a critical role in preventing apoptosis (3) (4) (5) (6) (7) . Human NF-B is composed of a homodimer or heterodimer of proteins than belong to the rel family, including p65, p50, c-rel, and rel-B. NF-B proteins are normally retained in the cytoplasm by members of the inhibitor of B (IB) family (4) (5) (6) . However, a variety of agonists can stimulate cell signaling pathways that release NF-B factors. NF-B proteins then translocate into the nucleus and activate transcription of proinflammatory genes and also transcription of antiapoptotic genes, including cIAP1, XIAP, c-FLIP, Bcl-2, and Bcl-X L. NF-B activation can prevent apoptosis that would otherwise be induced by cytotoxic proteins such as TNF-␣. Activation of apoptosis by TNF-␣ depends in part on deactivation of NF-B signaling (8) (9) (10) . Inhibition of the antiapoptotic effects of NF-B may be beneficial to the host during viral infection, decreasing viral replication and increasing host survival.
We hypothesized that components of the apoptotic pathway serve as intracellular sensors for viral infection. Host substrates in the apoptotic pathway that are cleaved by viral proteases might activate apoptosis, thereby limiting viral replication. We now show that the Coxsackievirus protease 3C pro cleaves IB␣, generating an IB␣ fragment that represses NF-B signaling, blocks the antiapoptotic effects of NF-B, and decreases viral replication.
Results
Coxsackievirus B3 (CVB3) Induces Apoptosis. CVB3 infection of HeLa cells causes apoptosis, as detected by DAPI staining of nuclear chromatin after infection, nucleosomal fragments, and poly(ADP-ribose) polymerase (PARP) cleavage (Fig. 1) . Because NF-B signaling regulates apoptosis, we next explored the effect of Coxsackievirus infection upon nuclear translocation of NF-B. HeLa cells were infected with CVB3 for 0-240 min or treated with TNF-␣ for 30 min as a control, and nuclear localization of the NF-B p65 subunit was assayed by immunoblotting and immunohistochemistry. After infection with CVB3, NF-B appears in the nucleus, although more slowly than after TNF-␣ treatment. We therefore sought to characterize more fully the effects of viral infection upon NF-B signal transduction.
CVB3 Infection Does Not Activate NF-B.
We then examined the effect of CVB3 infection on NF-B activation. HeLa cells were infected with CVB3 or treated 30 min with TNF-␣. Nuclear extracts were isolated and subjected to EMSA with radiolabeled NF-B oligonucleotide DNA binding domain sequence (Fig. 2C  Left) . In addition, HeLa cells were transiently transfected with a B-luciferase reporter construct, and then treated with TNF-␣ or CVB3 (Fig. 2C Right) . TNF-␣ significantly increases NF-B DNA binding and transactivation, as expected ( (Fig. 2C Right) . Not only does CVB3 infection fail to activate a B reporter construct, but in addition CVB3 inhibits TNF-␣-mediated NF-B transactivation (Fig. 7 , which is published as supporting information on the PNAS web site). (These experiments included an internal control, cotransfection with a vector expressing Renilla luciferase driven by a CMV promoter.) Taken together, these data suggest a paradox: although CVB3 infection leads to nuclear localization of NF-B, CVB3 inhibits NF-B binding activity and transactivation.
CVB3 Infection Alters IB␣ Location. To study how CVB3 inhibits NF-B binding and transactivation, we localized IB␣ in HeLa cells. CVB3 infection does not change steady-state levels of IB␣ (Fig. 3A) . However, we detected an additional 30-kDa IB␣ fragment in infected HeLa cells, total cell extracts (Fig. 3A  Upper) , or nuclear extracts (Fig. 3A Lower) . The fragment of IB␣ within the nucleus is bound to NF-B, because immunoprecipitants prepared from nuclei of infected cells with antibody to the NF-B p65 subunit contain the amino-terminal IB␣ fragment (Fig. 3B ). These findings suggest that CVB3 infection leads to cleavage of IB␣. Furthermore, a fragment of IB␣ enters the nucleus where it interacts with NF-B.
The CVB3 Protease 3C pro Cleaves IB␣. We postulated that the IB␣-immunoreactive fragment detected after Coxsackievirus infection is generated by a viral protease cleaving IB␣. The primary structure of IB␣ contains two consensus sequences for the CVB3 viral protease 3C pro : AXXQG at residues 151-155 and QG at residues 249-250 (Fig. 3C ). To determine whether or not 3C pro can cleave IB␣, we incubated recombinant 3C pro with the recombinant 65-kDa fusion polypeptide GST-IB␣ and immunoblotted the mixture with antibodies to IB␣. The 3C pro protease cleaves recombinant IB␣ in vitro (Fig. 3D) , as detected by immunoblotting with antibody to the amino terminus of IB␣ (Fig. 3D, lanes 2-4) , and with antibody to the carboxyl terminus of IB␣ (Fig. 3D, lane 5) . As a control, a partially inactive catalytic mutant 3C pro (C147S) was unable to cleave IB␣ with high efficiency (Fig. 8 , which is published as supporting information on the PNAS web site) (11) .
To determine the precise location at which 3C pro cleaves IB␣, we constructed mutant IB␣ polypeptides lacking either one of the two 3C pro recognition sequences, IB␣(Q154G) or IB␣(Q249G). The 3C pro protease cleaves WT IB␣ and mutant IB␣(Q154G) (Fig. 3E) . However, 3C
pro protease cannot cleave mutant IB␣(Q249G), suggesting that 3C pro cleaves IB␣ between Q249 and G250 (Fig. 3E) . We next defined the location of the IB␣ fragment in the cell. We transfected HeLa cells with empty vector (control), vector expressing WT IB␣ [IB␣(WT)], or vector expressing the amino-terminal fragment of IB␣ generated by the viral protease [IB␣(1-249)]. We treated these transfected cells with TNF-␣ to trigger NF-B translocation to the nucleus, and then washed away the TNF-␣ to allow the cells to return to rest. We then monitored the location of the NF-B p65 subunit and IB␣.
Expression of the IB␣ fragment changes the location of NF-B. In control cells, NF-B normally is found in the cytoplasm; NF-B translocates to the nucleus after TNF-␣ treatment, and then NF-B is found in the cytoplasm again after TNF-␣ is washed away (Fig. 4A Top) . Expression of WT IB␣ does not change this normal pattern NF-B localization (Fig. 4A  Middle) . However, expression of the IB␣(1-249) fragment causes NF-B to remain in the nucleus after TNF-␣ is washed away (Fig. 4A Bottom) .
Furthermore, the location of the IB␣ fragment is different from the location of the full-length IB␣. The WT IB␣ is found in the cytoplasm of resting cells (Fig. 4A Middle) . IB␣ disappears from the cell during TNF-␣ treatment, and then IB␣ accumulates again in the cytoplasm after TNF-␣ is removed (Fig.  4A Middle) . In contrast, the IB␣ fragment is found in the nucleus instead of the cytoplasm after TNF-␣ is washed away (Fig. 4A Bottom) .
In summary, our data show that an IB␣ fragment is localized to the nucleus, and that expression of this fragment causes NF-B to remain in the nucleus.
The Viral Protease Generates an IB␣ Fragment That Remains in the
Nucleus. To prove that the viral protease generates an IB␣ fragment, we overexpressed the viral protease 3C pro in HeLa cells. We also expressed the full-length IB␣ and tagged the IB␣ at the amino terminus with FLAG and at the carboxyl terminus with c-myc. We again stimulated the transfected cells with TNF-␣ and followed the location of the amino terminus and carboxyl terminus of IB␣.
The viral protease 3C pro leads to the appearance of the amino-terminus FLAG tag but not the carboxyl-terminus myc tag (Fig. 4B) . This finding suggests that the viral protease generates an amino-terminal fragment of IB␣. Furthermore, the FLAG epitope is found in the nucleus, supporting the idea that the IB␣ fragment translocates into the nucleus (Fig. 4B) . Finally, the viral protease also causes NF-B to colocalize with IB␣ in the nucleus (Fig. 4B) . In contrast, expression of fulllength IB␣ without the viral protease leads to normal NF-B . Cells were fixed, permeabilized, and assayed for p65 (FITC, green) and IB␣ (Cy3, red) by confocal microscopy (n ϭ 3). (B) HeLa cells were transfected with a plasmid expressing 3C pro and cotransfected with a plasmid expressing the fusion protein FLAG-IB␣(WT)-myc. Cells were treated as before and assayed for the FLAG-tagged amino-terminal IB␣ fragment or the myctagged carboxyl-terminal IB␣ fragment (red) and for p65 (green) (n ϭ 3). (Magnification: ϫ60.) localization in the cytoplasm (Fig. 4A Middle) . A partially inactive mutant 3C pro (C147S) did not induce NF-B translocation to the nucleus (Fig. 9 , which is published as supporting information on the PNAS web site) (11) .
Thus the viral protease generates an amino-terminal IB␣ fragment that colocalizes with NF-B in the nucleus.
The IB␣ Fragment Increases Apoptosis. We next explored the functional consequences of viral protease cleavage of IB␣. We hypothesized that viral infection causes apoptosis by the viral protease cleaving IB␣. To test this idea, we first constructed a mammalian expression vector pZn3C pro that encodes the Coxsackievirus protease 3C
pro under control of a zinc-responsive promoter (Fig. 5A) . Expression of 3C pro causes apoptosis of HeLa cells (Fig. 5A) . We then expressed 3C pro in HeLa cells transfected with a vector expressing IB␣(WT) or cleavageresistant IB␣(Q249G), and then measured apoptosis.
The viral protease expression activates apoptosis, but expression of cleavage-resistant IB␣ blocks apoptosis (Fig. 5B) . The ability of the viral protease to cause apoptosis is limited by expression of a mutant IB␣ that is resistant to protease cleavage. This finding suggests that the viral protease activates apoptosis in part by cleaving IB␣. These data also suggest that the IB␣ fragment cleaved by the viral protease increases apoptosis of infected cells. To demonstrate that the IB␣ fragment can cause apoptosis, we transiently expressed IB␣(WT) (control) or the amino-terminal fragment of IB␣ [IB␣(1-249)] in HeLa cells and measured apoptosis. The IB␣ fragment increases apoptosis (Fig. 5C ). This result suggests that 3C pro induces apoptosis in part through proteolysis of IB␣.
IB␣ Increases Apoptosis During Viral Infection.
To support the hypothesis that IB␣ plays a critical role in the host response to Coxsackievirus infection, we silenced IB␣ expression by RNA interference (Fig. 6A) . Silencing IB␣ expression decreases apoptosis induced by viral infection (Fig. 6B Upper) and increases NF-B activity (Fig. 6B Lower) . Silencing IB␣ expression also permits an increase in viral replication (Fig. 6C) . Finally, expressing a cleavage-resistant IB␣ permits an increase in viral replication (Fig. 6D) . These data suggest that IB␣ regulates apoptosis during viral infection.
Discussion
The major finding of our study is that a viral protease cleaves IB␣, generating an IB␣ fragment. This IB␣ fragment enters the nucleus, interacts with NF-B, and inhibits NF-B transactivation. As a consequence, the antiapoptotic effects of NF-B are suppressed and apoptosis increases, thereby limiting viral replication. IB␣ may thus act as a host sensor for viral infection. Coxsackievirus and other Picornaviruses cause apoptosis of infected cells in vivo and in vitro (12) (13) (14) (15) (16) (17) . Although expression of individual enterovirus polypeptides can cause apoptosis in vitro, it is unclear precisely how these viral polypeptides cause apoptosis (18) (19) (20) (21) . Our study shows that the Coxsackievirus protease 3C pro is sufficient to cause apoptosis, in part by cleaving IB␣.
Several lines of evidence suggest that the viral protease 3Cpro generates an IB␣ fragment that interrupts NF-B signaling. The viral protease generates an IB␣ fragment both in vitro (Fig.  3D ) and in cells (Figs. 3A and 4B) . The IB␣ fragment interacts with and retains NF-B in the nucleus (Figs. 3B and 4) . The IB␣ fragment also increases apoptosis (Fig. 5C ). Taken together, these data suggest that the IB␣ fragment generated by the viral protease can interfere with NF-B signaling.
Other laboratories have shown that host proteases can cleave IB␣. Activation of apoptosis by TNF-␣ leads to caspase-3 cleavage of IB␣ in vitro, suppressing NF-B signaling and sensitizing cells to apoptosis (22, 23) . Our data extend these previous studies by showing that viral protease cleavage of IB␣ can disrupt NF-B signaling, facilitate apoptosis, and decrease viral replication.
Because NF-B modulates many innate and adaptive immune pathways, disruption of NF-B signaling would be expected to have multiple consequences to the infected host. NF-B signaling may play a dual role during viral infection of the host. In noninfected cells activated by adjacent infected cells, activation of NF-B pathways may induce transcription of sets of genes, leading to enhanced expression of immune effector molecules. It is also possible that in infected cells viral infection shuts down NF-B-induced transcription of antiviral genes. Furthermore, in infected cells inactivation of NF-B may decrease transcription of antiapoptotic genes, increasing apoptosis of infected cells and limiting viral replication. Our data fit with studies by Knowlton and coworkers (24) that show that survival of p50 null mice is greater than survival of WT mice after viral infection, in part because of increased apoptosis and decreased viral replication. These data of Knowlton and coworkers emphasize the importance of NF-B in regulating apoptosis during viral infection in vivo. The current study suggests that inactivation of NF-B signaling in infected cells is a direct consequence of viral protease processing of IB␣.
The innate immune system recognizes pathogen-associated molecular patterns (PAMPs) that are necessary for the survival of specific pathogens. Viral proteases are PAMPs that play a critical role in the life cycle of Picornaviruses and many other RNA viruses. Susceptibility to viral proteases may be a novel mechanism by which the host recognizes and responds to viral infections.
Methods
Cells and Viruses. CVB3 (Nancy strain) was propagated in HeLa cells as described (13) . The cells were cultured in MEM (Invitrogen, Carlsbad, CA) supplemented with 1% L-glutamate (100 mM), 100 units͞ml penicillin, 100 g͞ml streptomycin, and 10% FCS. Infected cells were fed in medium with 1% serum. Viral stocks were prepared by the infection of 150-cm 2 flask, 80-90% confluent monolayer culture of HeLa cells, at a multiplicity of infection of 1. Two days after incubation at 37°C, the cells were frozen and thawed three times, and the suspension was centrifuged. Viral supernatants were titered and stored at Ϫ80°C. Virus titers were performed by the plaque assay method (13) . CVB3 stock titer was of 2 ϫ 10 9 pfu͞ml.
Assays for Apoptosis. Apoptosis was measured by several complementary techniques, including DAPI staining (Molecular Probes, Carlsbad, CA), immunoblotting for PARP (a caspase substrate) detection by immunoblot, an ELISA that detects oligonucleotides and histones released as result of apoptosis (Cell Death Detection ELISA; Roche, Indianapolis, IN), and flow cytometry analysis (FACS) using propidium iodide (Sigma, St. Louis, MO) and annexin V-FITC (Dakocytomation, Fort Collins, CO), following the manufacturer's instructions.
Western Blot Analysis. Cells were lysed in 1ϫ lysis buffer (50 mM Tris, 1 mM EDTA, 1 mM EGTA, 0.17 g͞ml PMSF, and 2 g͞ml protein inhibitors: leupeptin, pepstatin, antipain, and antitrypsin). The homogenate was briefly centrifuged, and supernatants were collected. Proteins were quantified by Coomassie assay, and the samples were stored at Ϫ20°C. Fifty micrograms of cell homogenate was fractionated by SDS͞PAGE and then transferred to a nylon membrane, blocked, incubated with primary antibodies and with secondary antibodies conjugated to HRP, and detected by chemiluminescence (ECL; Amersham, Piscataway, NJ). Human anti-PARP monoclonal antibody was from Trevigen (Gaithersburg, MD). Polyclonal anti-p65, IB␣ antibodies, polyclonal anti-Bcl 2 , polyclonal anti-Bcl-X L , polyclonal anti-c-myc, polyclonal anti-lamin-A, polyclonal anti-␤-actin, and monoclonal anti-GST antibody were from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal anti-FLAG was from Sigma.
Immunoprecipitation. Extracts from whole lysates or nuclear purified were precleared with control IgG corresponding to the host of the primary antibody, together with protein ASepharose. After centrifugation, the cell lysate was incubated overnight with the appropriate antibody and protein ASepharose. The pellets were collected by centrifugation, washed three times with RIPA buffer (0.15 mM NaCl͞0.05 mM Tris⅐HCl, pH 7.2͞1% Triton X-100͞1% sodium deoxycholate͞ 0.1% SDS), and resuspended with electrophoresis sample buffer.
Immunocytochemistry. HeLa cells were grown in cover slides and incubated with anti-p65 (Santa Cruz Biotechnology) and anti-N-terminal-IB␣ (Santa Cruz Biotechnology) or anti-p65 and anti-C-terminal-IB␣ (Santa Cruz Biotechnology) antibodies for 2 h. Covers were washed twice with PBS-0.1% BSA and then incubated with anti-FITC (p65, green), anti-Cy3 (IkB, red), and Hoecht (nuclear detection, blue) for 1 h. Covers were washed four times with PBS-0.1% BSA and mounted in microscope slides for confocal microscopy visualization of the proteins.
Expression and Purification of Recombinant Proteins. CVB3 3C pro was expressed in bacteria and purified as described (11) . In brief, we constructed a prokaryotic expression vector encoding a fusion polypeptide encoding (His) 6 -3C pro (11) . CVB3(His) 6 -3C pro was expressed in bacteria and purified by metal chelation chromatography, dialyzed, and stored at Ϫ80°C.
The IB␣ cDNA was kindly provided by Sankar Ghosh (Yale University, New Haven, CT). Mutant IB␣ expression vectors were constructed by site-directed mutagenesis using a kit (Stratagene, La Jolla, CA). Oligonucleotide primers used to generate mutant IB␣ constructs were: IB␣(Q154G) primer, 5Ј-GCCTGTGAGGGGGGCT-3Ј; IB␣(Q249G) primer, 5Ј-GT-TACCTACGGGGGC-3Ј. IB␣(WT), IB␣(Q154G), and IB␣(Q249G) were expressed and 35 S-methionine-radiolabeled by
